Evaluating the value of circulating miR-21, miR-210 and miR-942 in the diagnosis of early-stage lung adenocarcinoma
Rong Li, Guangmei Chen, Yue Shao, Xiaohan Jin, Ziyi Zhang, Wei Wu, Mengnan Sun, Lichuan Zhang · 2025
Read Evaluating the value of circulating miR-21, miR-210 and miR-942 in the diagnosis of early-stage lung adenocarcinoma by Rong Li, Guangmei Chen, Yue Shao, Xiaohan Jin, Ziyi Zhang, Wei Wu, Mengnan Sun, Lichuan Zhang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12752317.txt.
Description
Rong Li and colleagues test three blood microRNAs for early lung adenocarcinoma diagnosis. Their study from twenty twenty-five draws blood before lung surgery. This lung cancer type is rising and hard to catch early. Small RNA molecules in blood may betray tumours sooner.
Patients with suspicious lung nodules gave samples before operations. Pathology after surgery confirmed which cases were early cancer. Healthy volunteers supplied the comparison blood samples. A combined model used all three microRNAs together. Performance checks judged how well the model separated the groups. Single markers alone were weaker than the combined panel. Blood-based triage could help decide which nodules need surgery.
Catalog record
| CREATOR | Rong Li, Guangmei Chen, Yue Shao, Xiaohan Jin, Ziyi Zhang, Wei Wu, Mengnan Sun, Lichuan Zhang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |